Hood Leroy
President, Institute for Systems Biology, Seattle, WA, USA.
Rambam Maimonides Med J. 2013 Apr 30;4(2):e0012. doi: 10.5041/RMMJ.10112. Print 2013 Apr.
Studying complex biological systems in a holistic rather than a "one gene or one protein" at a time approach requires the concerted effort of scientists from a wide variety of disciplines. The Institute for Systems Biology (ISB) has seamlessly integrated these disparate fields to create a cross-disciplinary platform and culture in which "biology drives technology drives computation." To achieve this platform/culture, it has been necessary for cross-disciplinary ISB scientists to learn one another's languages and work together effectively in teams. The focus of this "systems" approach on disease has led to a discipline denoted systems medicine. The advent of technological breakthroughs in the fields of genomics, proteomics, and, indeed, the other "omics" is catalyzing striking advances in systems medicine that have and are transforming diagnostic and therapeutic strategies. Systems medicine has united genomics and genetics through family genomics to more readily identify disease genes. It has made blood a window into health and disease. It is leading to the stratification of diseases (division into discrete subtypes) for proper impedance match against drugs and the stratification of patients into subgroups that respond to environmental challenges in a similar manner (e.g. response to drugs, response to toxins, etc.). The convergence of patient-activated social networks, big data and their analytics, and systems medicine has led to a P4 medicine that is predictive, preventive, personalized, and participatory. Medicine will focus on each individual. It will become proactive in nature. It will increasingly focus on wellness rather than disease. For example, in 10 years each patient will be surrounded by a virtual cloud of billions of data points, and we will have the tools to reduce this enormous data dimensionality into simple hypotheses about how to optimize wellness and avoid disease for each individual. P4 medicine will be able to detect and treat perturbations in healthy individuals long before disease symptoms appear, thus optimizing the wellness of individuals and avoiding disease. P4 medicine will 1) improve health care, 2) reduce the cost of health care, and 3) stimulate innovation and new company creation. Health care is not the only subject that can benefit from such integrative, cross-disciplinary, and systems-driven platforms and cultures. Many other challenges plaguing our planet, such as energy, environment, nutrition, and agriculture can be transformed by using such an integrated and systems-driven approach.
以整体的方式而非一次只研究“一个基因或一种蛋白质”的方式来研究复杂的生物系统,需要来自广泛学科的科学家共同努力。系统生物学研究所(ISB)已经无缝整合了这些不同的领域,创建了一个跨学科平台和一种“生物学驱动技术驱动计算”的文化。为了实现这个平台/文化,跨学科的ISB科学家们有必要相互学习彼此的语言,并在团队中有效地合作。这种“系统”方法对疾病的关注催生了一门名为系统医学的学科。基因组学、蛋白质组学以及其他“组学”领域的技术突破正在催化系统医学取得显著进展,这些进展已经并正在改变诊断和治疗策略。系统医学通过家族基因组学将基因组学和遗传学结合起来,以便更轻松地识别疾病基因。它使血液成为了解健康与疾病的窗口。它正促使疾病分层(分为离散的亚型),以便与药物进行适当的阻抗匹配,并将患者分为对环境挑战有相似反应的亚组(例如对药物的反应、对毒素的反应等)。患者激活的社交网络、大数据及其分析与系统医学的融合催生了一种预测性、预防性、个性化和参与性的P4医学。医学将关注每一个个体。它将在本质上变得积极主动。它将越来越关注健康而非疾病。例如,10年后,每个患者都将被数十亿个数据点的虚拟云所包围,并且我们将拥有工具,将这些海量数据维度简化为关于如何为每个个体优化健康和避免疾病的简单假设。P4医学将能够在疾病症状出现之前很久就检测和治疗健康个体中的紊乱情况,从而优化个体的健康并避免疾病。P4医学将:1)改善医疗保健;2)降低医疗保健成本;3)刺激创新和新公司的创立。医疗保健并非唯一能从这种整合性、跨学科且由系统驱动的平台和文化中受益的领域。困扰我们星球的许多其他挑战,如能源、环境、营养和农业等,都可以通过使用这种综合且由系统驱动的方法得到改变。